Author reply: To PMID 23972322

Affiliations

¹ Tennessee Retina, PC, Nashville, Tennessee.
² Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
³ Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Canada.
⁴ The Ottawa Hospital Research Institute and the Division of Hematology, University of Ottawa Department of Medicine, Ottawa, Canada; The Arctic Group of Companies, Toronto, Canada.

Comment

Carl C Awh et al. Ophthalmology. 2014 Aug.

. 2014 Aug;121(8):e39.

doi: 10.1016/j.ophtha.2014.02.029. Epub 2014 May 2.

¹ Tennessee Retina, PC, Nashville, Tennessee.
² Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
³ Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Canada.
⁴ The Ottawa Hospital Research Institute and the Division of Hematology, University of Ottawa Department of Medicine, Ottawa, Canada; The Arctic Group of Companies, Toronto, Canada.

No abstract available

Comment on

CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration.
Awh CC, Lane AM, Hawken S, Zanke B, Kim IK. Awh CC, et al. Ophthalmology. 2013 Nov;120(11):2317-23. doi: 10.1016/j.ophtha.2013.07.039. Epub 2013 Aug 21. Ophthalmology. 2013. PMID: 23972322 Clinical Trial.
Re: Awh et al.: CFH and ARMS2 Genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration (Ophthalmology 2013;120:2317-23).
Schwartz SG. Schwartz SG. Ophthalmology. 2014 Aug;121(8):e38. doi: 10.1016/j.ophtha.2013.12.046. Epub 2014 May 2. Ophthalmology. 2014. PMID: 24793508 No abstract available.